Last $1.94 USD
Change Today -0.03 / -1.52%
Volume 2.4M
GERN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hoyoung Huh M.D., Ph.D.

Chairman and Member of Nominating & Corporate Governance Committee, Geron Corporation
AgeTotal Calculated CompensationThis person is connected to 116 board members in 8 different organizations across 10 different industries.

See Board Relationships
44$100,428

Background*

Dr. Hoyoung Huh, M.D., Ph.D., served as the Chief Executive Officer and President of BiPar Sciences, Inc. from March 3, 2008 to December 1, 2009. Dr. Huh served as the Chief Operating Officer and Head of the PEGylation Business Unit of Nektar Therapeutics from May 2007 to February 29, 2008 and served as its Senior Vice President of Business Development and Marketing. Dr. Huh is a leading advisor to biotechnology, healthcare and investment companies around the globe and ...

Read Full Background

Corporate Headquarters*

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-473-7700
Fax: 650-473-7750

Board Members Memberships*

Director
Chairman and Chairman of BiPar Innovation Board
Chairman
2008-2009
Former Director
2009-N/A
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Scientific Review Committee
2009-N/A
Former Chairman
2010-Present
Chairman and Member of Nominating & Corporate Governance Committee
2010-Present
Director
2011-Present
Director and Chairman of Nomination Committee
2012-Present
Chairman of The Board
2013-N/A
Director
2013-Present
Director

Education*

PhD
Cornell University
MD
Cornell University
Bachelor's Degree
Dartmouth College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,553
Total Calculated Compensation$100,428
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $1.94 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$760.5K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Lode Debrabandere Ph.D., MBAChief Executive Officer, President and Director
Osiris Therapeutics, Inc.
$366.8K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.